Black Diamond Therapeutics Inc. (BDTX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-04
4:12 pm
Purchase
2021-12-3113GBlack Diamond Therapeutics, Inc.
BDTX
BlackRock Inc.
BLK
2,248,467
6.200%
2,248,467increase
(New Position)
Filing
History
2021-02-11
4:58 pm
Purchase
2021-02-0313GBlack Diamond Therapeutics, Inc.
BDTX
BB BIOTECH AG1,900,000
5.300%
1,900,000increase
(New Position)
Filing
History
2021-02-10
10:39 am
Purchase
2020-12-3113GBlack Diamond Therapeutics, Inc.
BDTX
VANGUARD GROUP INC1,845,962
5.130%
1,845,962increase
(New Position)
Filing
History
2020-12-03
4:47 pm
Sale
2020-11-2313DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.4,328,883
12.000%
-1,031,634decrease
(-19.25%)
Filing
History
2020-11-20
5:32 pm
Sale
2020-11-1113DBlack Diamond Therapeutics, Inc.
BDTX
Versant Venture Capital VI L.P.5,360,517
14.900%
-980,734decrease
(-15.47%)
Filing
History
Goto Prev, 0, 1